Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Austria Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20052
20062
20073
20081
20101
20142
20161
20172
20182
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated6
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Boehringer Ingelheim3
Bristol-Myers Squibb2
Daiichi Sankyo2
AstraZeneca1
Atrial Fibrillation Network1
Bayer1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation23
Stroke4
Atrial Flutter3
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Acute Coronary Syndrome1
Atherosclerosis1
Basal Ganglia Hemorrhage1
Cerebral Hemorrhage1
Coronary Artery Disease1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.